Powering decisions with outcomes research

Outcomes research provides the framework to measure the real-world impact of health technologies on patients, clinicians and health systems, capturing the patient’s voice. We specialise in providing outcomes research services designed to support both industry and health system clients, providing the insights required to inform strategy, strengthen value propositions, and meet the demands of HTA bodies and payers.

How can YHEC’s outcomes research expertise help you?

Our research provides the evidence needed to:

  • Prepare for regulatory and reimbursement submissions: Generating robust, patient-centred evidence to support submissions and reimbursement decisions. YHEC’s outcomes research can also inform economic evaluations, using utility elicitation methods (such as time-trade off and standard gamble) to quantify health state utilities.
  • Support value-based healthcare: Linking outcomes to patient experience, resource use, and long-term impact to inform pricing, contracting and service delivery models. To do this, we use patient preference studies to reveal what patients and stakeholders truly value.
  • Drive real-world change and clinical adoption: Ensuring outcomes evidence is built into policy, practice and product implementation. We use clinical outcome assessments (including patient-reported outcomes) to incorporate the patient’s lived experience in the evidence.
  • Quantify uncertainty: Undertaking structured expert elicitation to quantify uncertainty and generate expert consensus on key evidence gaps or missing economic model inputs.

Why partner with YHEC?

Choosing YHEC for your outcomes research needs means partnering with a team that offers:

YHEC is skilled at translating complex research findings into clear, practical and actionable recommendations. Our focus is on providing you with implementable strategies that directly address your research questions and support your strategic objectives. From patient preference studies and utility elicitation techniques to structured expert elicitation, we tailor methods to your objectives and needs.

Our unique link with the University of York provides access to their Health Sciences’ Research Governance Committee. This allows us to secure ethical approval for our studies as required, ensuring all research is conducted to the highest standards.

Our research is underpinned by academic rigour and transparent methodologies. We ensure all studies adhere to scientific standards, and our established track record of publications builds trust in our findings. We are trusted by industry and health systems globally, with experience using outcomes research to support HTA submissions and evidence generation for rare diseases.

We have a proven track record of delivering projects on time and to the highest quality. We understand the time-sensitive nature of evidence generation and work closely with our clients to ensure efficient project management and timely delivery of all key outputs.

You may also be interested in

Peer-reviewed publication

Patterns of Responses in Time Trade-Off Studies: A Latent Class Analysis of Health States Worse Than Dead

YHEC authors: Adam Smith, Stuart Mealing, Andria Joseph
Publication date: March 2025
Journal: Journal of Medical Economics

Abstract

AIM: The study was to characterize participant responses in a time trade-off (TTO) task involving states worse than dead (WTD) to determine patterns of congruence and incongruence. METHODS: The online...

Peer-reviewed publication

I-PreFer Study: A Discrete Choice Experiment to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Pharmacological Treatment Options

YHEC authors: Tom Bromilow, Adam Smith, Stuart Mealing, Damian Lewis
Publication date: July 2023
Journal: Patient Preference and Adherence

Abstract

PURPOSE: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and ultimately fatal lung disease that, while rare, has seen incidence rise over time. There is no cure for IPF other...

Peer-reviewed publication

I-PreFer Study: A Questionnaire to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Treatment Options

YHEC authors: Tom Bromilow, Adam Smith, Stuart Mealing, Damian Lewis
Publication date: June 2023
Journal: Patient Preference and Adherence

Abstract

INTRODUCTION: Idiopathic Pulmonary Fibrosis (IPF) is a rare disease that causes shortness of breath, dry cough, and tiredness. While there is no cure for IPF, current therapeutic treatments aim to...

Talk to our expert

For more information about outcomes research, talk to our expert – Andria Joseph.

A headshot of Andria Joseph